Growth Metrics

Aurinia Pharmaceuticals (AUPH) Change in Acquisitions & Divestments (2021 - 2025)

Aurinia Pharmaceuticals' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $145.3 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 17.25% year-over-year to $145.3 million; the TTM value through Dec 2025 reached $494.1 million, down 15.59%, while the annual FY2025 figure was $494.1 million, 15.59% down from the prior year.
  • Change in Acquisitions & Divestments reached $145.3 million in Q4 2025 per AUPH's latest filing, up from $93.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $170.5 million in Q1 2024 to a low of $60.9 million in Q1 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $121.4 million, with a median of $120.5 million recorded in 2022.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 81.43% in 2022, then decreased 29.47% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $90.7 million in 2021, then surged by 30.36% to $118.2 million in 2022, then increased by 16.82% to $138.1 million in 2023, then fell by 10.22% to $124.0 million in 2024, then grew by 17.25% to $145.3 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Change in Acquisitions & Divestments are $145.3 million (Q4 2025), $93.5 million (Q3 2025), and $132.2 million (Q2 2025).